Topics: CTN Impact & Implementation
Events
News
-
Registrations open: Super webinar
-
Optimising the value of clinical trials – impact and implementation forum
-
ACTA Teletrials Project – CTN and CC survey
-
Successful 2021 ACTA ASM
-
Value of Clinical Trials: Impact and Implementation Forum presentations online
-
Guidance on Implementability and Super Webinar
-
ACTA—a year in review, 2018-2019 financial year
-
Did you miss our Research Prioritisation Uncovered workshops?
Resources
-
Strategies for supporting more trials of high value
-
What clinical trialists should know about healthcare policy
-
Improving impact of clinical trials through implementability
-
ACTA 2020-2021 Annual Report
-
The Health Service Provider’s Perspective: How should we measure impact on service delivery?
-
ANZCA CTN: Impact and Implementation
-
Research Prioritisation Uncovered – Workshop 1 recording
-
ACTA 2021-2022 Annual Report
-
What we don’t know about the health and economic benefit of trials and registries in Australia
-
ALLG Clinical Trials Impact and Implementation
-
Implementability Super Webinar slide deck
-
Implementability Guidance Document: After The Trial
-
Approaches to implementability, implementation and impact of clinical trials: a survey of Australian clinical trials networks and coordinating centres
-
Cochrane’s approach to implementation
-
The role of AHRTCs in optimising implementation of evidence into practice and policy
-
Understanding implementability in clinical trials: a pragmatic review and concept map
-
Health system sustainability and continuous self-improvement
-
What a trialist should know about implementation to practice
-
Guidance on Implementability
-
Research Prioritisation Uncovered – Workshop 2 recording
-
The Clinician Researcher’s Perspective: Measuring impact on individual clinical practice
-
Implementation of evidence by the ANZICS Clinical Trials Group
-
Assessing the impact of clinical trials: a scoping literature review
-
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results